全文获取类型
收费全文 | 7780篇 |
免费 | 420篇 |
国内免费 | 42篇 |
专业分类
耳鼻咽喉 | 73篇 |
儿科学 | 413篇 |
妇产科学 | 188篇 |
基础医学 | 1097篇 |
口腔科学 | 365篇 |
临床医学 | 711篇 |
内科学 | 1730篇 |
皮肤病学 | 198篇 |
神经病学 | 741篇 |
特种医学 | 195篇 |
外科学 | 1027篇 |
综合类 | 45篇 |
一般理论 | 4篇 |
预防医学 | 449篇 |
眼科学 | 148篇 |
药学 | 456篇 |
中国医学 | 24篇 |
肿瘤学 | 378篇 |
出版年
2023年 | 52篇 |
2022年 | 123篇 |
2021年 | 237篇 |
2020年 | 120篇 |
2019年 | 188篇 |
2018年 | 226篇 |
2017年 | 161篇 |
2016年 | 229篇 |
2015年 | 244篇 |
2014年 | 250篇 |
2013年 | 373篇 |
2012年 | 564篇 |
2011年 | 558篇 |
2010年 | 325篇 |
2009年 | 308篇 |
2008年 | 478篇 |
2007年 | 509篇 |
2006年 | 419篇 |
2005年 | 410篇 |
2004年 | 404篇 |
2003年 | 312篇 |
2002年 | 323篇 |
2001年 | 69篇 |
2000年 | 39篇 |
1999年 | 55篇 |
1998年 | 53篇 |
1997年 | 56篇 |
1996年 | 47篇 |
1995年 | 34篇 |
1994年 | 26篇 |
1993年 | 47篇 |
1992年 | 29篇 |
1991年 | 30篇 |
1990年 | 28篇 |
1989年 | 29篇 |
1988年 | 17篇 |
1987年 | 27篇 |
1985年 | 23篇 |
1984年 | 23篇 |
1983年 | 21篇 |
1982年 | 22篇 |
1981年 | 18篇 |
1980年 | 25篇 |
1978年 | 16篇 |
1977年 | 18篇 |
1976年 | 20篇 |
1975年 | 21篇 |
1931年 | 23篇 |
1923年 | 19篇 |
1916年 | 18篇 |
排序方式: 共有8242条查询结果,搜索用时 15 毫秒
101.
102.
103.
Nul D Zambrano C Diaz A Ferrante D Varini S Soifer S Grancelli H Doval H;Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina 《Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy》2005,19(2):125-134
Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA) studied whether a standardized protocol for the initiation and titration of the β-blocker carvedilol in a multicenter, open-label program would optimize β-blocker use in heart failure (HF) patients. The program included: (1) the carvedilol initiation and titration period, and (2) long-term follow-up at 6 and 12 months. Of 1299 patients in the registry, 504 were excluded due to current therapy; of the remaining 795 eligible patients, 293 were excluded due to contraindications. Of the included patients with follow-up data (n = 316), 93.3% tolerated carvedilol initiation and 47.7% of the patients reached the target dose of 50 mg/day for a mean dose of 39 mg/day. Rates were comparable in the elderly (n = 83), of which 53% achieved a target dose for a mean dose of 43.08 mg/day. This protocol improved therapy rates and achieved target doses quickly (average of 4 visits). Concomitant medications did not have to be adjusted and there were low withdrawal rates (10%) and hospital admissions (7.2%) for HF. Patients were able to maintain carvedilol therapy at 6 and 12 months. These results indicate that a standardized titration protocol, as used in GESICA, for the initiation and titration of β-blockers is well tolerated and may improve β-blocker use in carefully selected heart failure patients.The study authors are members of the GESICA Steering Committee and Subcommittees 相似文献
104.
Diosque P Padilla AM Cimino RO Cardozo RM Negrette OS Marco JD Zacca R Meza C Juarez A Rojo H Rey R Corrales RM Nasser JR Basombrío MA 《The American journal of tropical medicine and hygiene》2004,71(5):590-593
We studied the seroprevalence of antibodies against Trypanosoma cruzi in the human population along with domiciliary infestation by triatomine bugs in an area endemic for Chagas disease in the Chaco Province of Argentina. In addition, we carried out parasitologic surveys in patients, dogs, wild mammals, and vectors. The mean seroprevalence in humans was 27.81% (109 of 392) and 24.14% (63 of 261) in 1-15-year-old children. The minimum domiciliary infestation rate was 13.33%, with certain areas reaching 53.85%. The prevalence was 15.09% (16 of 106) in dogs and 35.71% (10 of 28) in opossums. Infection with T. cruzi was detected in 30.10% (59 of 196) of the Triatoma infestans tested. Compared with nationwide studies, our data suggest that 1) there are zones requiring immediate sanitary action, and 2) nationwide estimates are based on very heterogeneous epidemiologic situations. This heterogeneity emphasizes the importance of in-depth studies of restricted areas to provide additional information for a better understanding of the present status of Chagas disease in Argentina. 相似文献
105.
106.
107.
108.
Víctor Hugo Malo-Camacho Gerardo Enrique Bauelos-Díaz Víctor Hugo Martínez-Velzquez Luis Lpez-Ortega Oscar Malo-Macías Enrique Villarreal-Ríos Alejandro Sosa-Gallegos Mauricio Alva-Njera Mario Ivn Mejía-Valencia 《Medicine》2021,100(23)
Cohort study.This study aimed to determine the effectiveness of the universal approach of full endoscopy and percutaneous transpedicular fixation via a medial central approach (ACM) performed to surgically treat patients with lumbar degenerative surgical pathologies.Alternatives to interventionist treatments available to patients with lumbar degenerative surgical pathologies are related to recovery from minimally invasive surgery. Considering this, full endoscopic spinal decompression (full endoscopy) and percutaneous transpedicular fixation via an ACM represent advances in neurosurgical procedures, in particular, spinal surgery. Thus, the introduction of endoscopic and minimally invasive surgeries for the lumbar region has become 1 of the most important advances in modern surgery.A cohort of 79 patients undergoing full endoscopy and percutaneous transpedicular fixation was evaluated 6 times in 1 year. Pain intensity was measured using the visual analog scale (VAS), and lumbar functionality was measured using the Oswestry Disability Index (ODI). Six evaluations were performed: before surgery and on discharge after surgery as well as at 1, 3, 6, and 12 months after surgery.Before the ACM was applied, the VAS pain score was 8.52. At 11 hours post-surgery, the pain score reduced to 2.59 points (a difference of 5.73 points; P = 0.001). Of the 10 ODI domains evaluated, a difference was found between the period prior to surgery and 1 month later (P < 0.01).The universal approach to full endoscopy and lumbar percutaneous transpedicular fixation via an ACM is highly effective for patients with lumbar surgical degenerative pathologies. 相似文献
109.
110.
Increased incidence of adenocarcinomas at the gastro-oesophageal junction in Dutch males since the 1990s 总被引:7,自引:0,他引:7
Wijnhoven BP Louwman MW Tilanus HW Coebergh JW 《European journal of gastroenterology & hepatology》2002,14(2):115-122
BACKGROUND: Worldwide population-based studies suggest that the incidence of oesophageal and gastric cardia adenocarcinomas has increased since the 1970s. OBJECTIVE AND METHODS: We studied time trends in mortality and incidence rates of oesophageal and gastric carcinomas according to subsite and histology in the south-east Netherlands since 1978. RESULTS: The age-adjusted mortality and incidence rates for oesophageal cancer doubled in males over the entire 19-year study period from 2.7 to 5.6 and from 2.4 to 4.8 per 100,000 person years, respectively. In females, a similar trend for the mortality and incidence rates was seen, but at a lower level. The age-adjusted mortality and incidence rates for gastric cancer decreased with time from 20.7 to 12.8 and from 21.6 to 15.9 per 100,000 person years in males, respectively. In females, age-adjusted mortality and incidence rates for gastric cancer also decreased. Analysis of incidence rates by subsite and subtype showed an increase in adenocarcinomas of the oesophagus and gastric cardia, largely restricted to males. In females, the rise in incidence of squamous cell carcinoma of the oesophagus appeared to be more marked than the rise in adenocarcinomas, whereas the incidence of gastric cardia carcinomas has remained stable over the last 10 years. Neither the decrease in the number of unspecified tumours with time, nor the increase in the use of diagnostic endoscopy and imaging techniques, is likely to explain completely the observed increases. CONCLUSION: The increase in incidence of adenocarcinomas at the gastro-oesophageal junction in the south-eastern Netherlands seems, at least in part, to represent a true underlying increase that is restricted largely to males. 相似文献